NCT01855087View on ClinicalTrials.gov

Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes

CompletedOBSERVATIONAL
Timeline

Start Date

Not specified

Primary Completion Date

March 31, 2013

Conditions
Type 2 Diabetes
Trial Locations (1)

247-0056

Takai Naika Clinic, Kamakura

All Listed Sponsors
collaborator

The Japan Kidney Foundation

OTHER

lead

Kanagawa Physicians Association

OTHER

NCT01855087 - Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes | Biotech Hunter | Biotech Hunter